Johnson & Johnson (XSWX:JNJ) Non Operating Income: CHF-759 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:JNJ Johnson & Johnson XSWX:JNJ
24 GF Score
Price CHF207.40
GF Value CHF154.96
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Johnson & Johnson Non Operating Income?

Johnson & Johnson XSWX:JNJ 24 Non Operating Income is CHF-759 Mil as of Jun. 2026. GuruFocus rates XSWX:JNJ with a GF Score™ of 24/100 and a GF Value™ of CHF154.96 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Non Operating Income is income or expense that comes from miscellaneous sources. Johnson & Johnson's Non Operating Income for the three months ended in Jun. 2026 was CHF-292 Mil. Its Non Operating Income for the trailing twelve months (TTM) ended in Jun. 2026 was CHF-759 Mil.

Johnson & Johnson Non Operating Income Related Terms

Johnson & Johnson Non Operating Income Historical Data

* Premium members only.

The historical data trend for Johnson & Johnson's Non Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Johnson & Johnson Non Operating Income Chart

Johnson & Johnson Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Non Operating Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,505.84 -1,740.23 -6,430.65 -4,587.28 5,491.44

Johnson & Johnson Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Non Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -139.06 347.90 -529.94 -285.00 -291.74
XSWX:JNJ
24GF Score
Johnson & Johnson XSWX:JNJ
Non Operating Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Johnson & Johnson Non Operating Income Calculation

Non Operating Income is income or expense that comes from miscellaneous sources.

Non Operating Income for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF-759 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Non Operating Income →
What does a Non Operating Income of CHF-759 Mil mean?
Johnson & Johnson (XSWX:JNJ) has a Non Operating Income of CHF-759 Mil as of Jun. 2026. Non-operating Income represents the amount of income from one-time, nonrecurring events. View historical data on Johnson & Johnson and its competitors.
Is Johnson & Johnson's Non Operating Income too high?
Johnson & Johnson's current Non Operating Income is CHF-759 Mil. Overall, Johnson & Johnson has a GF Score™ of 24/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Johnson & Johnson's Non Operating Income compare to ABBV and MRK?
Johnson & Johnson's Non Operating Income of CHF-759 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Non Operating Income for a Drug Manufacturers company?
A good Non Operating Income depends on the Drug Manufacturers industry context. However, Non Operating Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Non Operating Income mean?
A high Non Operating Income can signal that a stock is expensive relative to its fundamentals. Non-operating Income represents the amount of income from one-time, nonrecurring events. View historical data on Johnson & Johnson and its competitors. Johnson & Johnson's current Non Operating Income is CHF-759 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Johnson & Johnson stock overvalued right now?
Based on GuruFocus' analysis, Johnson & Johnson (XSWX:JNJ) is currently considered Significantly Overvalued. The stock's GF Value™ is CHF154.96, compared to a current price of CHF207.40 — trading 33.8% above its estimated fair value. The current Non Operating Income is CHF-759 Mil. Johnson & Johnson's overall GF Score™ is 24/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Non Operating Income calculated?
Non Operating Income is calculated from a company's financial statements. For Johnson & Johnson (XSWX:JNJ), the current Non Operating Income is CHF-759 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Johnson & Johnson (XSWX:JNJ) Overvalued in 2026?

Based on GuruFocus' analysis, Johnson & Johnson stock appears to be overvalued. The current stock price of CHF207.40 is trading 33.8% above its estimated GF Value™ of CHF154.96. GuruFocus considers Johnson & Johnson to be Significantly Overvalued.

Key valuation signals for XSWX:JNJ:

  • Non Operating Income: CHF-759 Mil
  • GF Value™: CHF154.96 vs. price of CHF207.40 (33.8% above fair value)
  • GF Score™: 24/100 with 7 warning signs

No single metric tells the full story. See the XSWX:JNJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Johnson & Johnson Business Description

Address One Johnson & Johnson Plaza, New Brunswick, NJ, USA, 08933
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
24GF Score

Get the complete analysis for XSWX:JNJ

Non Operating Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF207.40
Price
CHF154.96
GF Value